Cynosure Company Profile (NASDAQ:CYNO)

About Cynosure

Cynosure Inc. (Cynosure) develops and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve gynecologic health. The Company operates through aesthetic treatment products and services segment. It markets radiofrequency (RF) energy sourced medical devices for precision surgical applications, such as facial plastic and general surgery; gynecology; ear, nose and throat procedures; ophthalmology; oral and maxillofacial surgery; podiatry, and proctology. The Company's product portfolio utilizes a range of energy sources, including Alexandrite, diode, neodymium-doped yttrium aluminum garnet (Nd: YAG), pulse dye, Q-switched lasers, intense pulsed light and RF technology.

Industry, Sector and Symbol:

Sector: Medical
Industry: Medical Appliances & Equipment
Sub-Industry: Health Care Equipment
Exchange: NASDAQ
Symbol: CYNO
CUSIP: 23257720

Key Metrics:

Previous Close: $52.73
50 Day Moving Average: $52.01
200 Day Moving Average: $48.86
52-Week Range: $29.60 - $55.94
Trailing P/E Ratio: 62.26
Foreward P/E Ratio: 28.05
P/E Growth: 1.84
Market Cap: $1.25B
Outstanding Shares: 23,731,000
Beta: 1.54

Profitability:

Net Margins: 5.09%
Return on Equity: 6.57%
Return on Assets: 5.09%

Debt:

Debt-to-Equity Ratio: 0.04%
Current Ratio: 3.17%
Quick Ratio: 2.34%

Additional Links:

Companies Related to Cynosure:

Consensus Ratings for Cynosure (NASDAQ:CYNO) (?)

Ratings Breakdown:	5 Buy Ratings
Consensus Rating:	Buy (Score: 3.00)
Consensus Price Target:	$62.00 (17.58% upside)

Analysts' Ratings History for Cynosure (NASDAQ:CYNO)

Show:

Date	Firm	Action	Rating	Price Target
9/14/2016	Brean Capital	Set Price Target	Buy	$60.00
7/27/2016	Northland Securities	Set Price Target	Buy	$55.00 -> $60.00
7/27/2016	Stifel Nicolaus	Reiterated Rating	Buy	$57.00 -> $62.00
7/27/2016	Maxim Group	Boost Price Target	Buy	$60.00 -> $66.00
4/27/2016	Leerink Swann	Reiterated Rating	Buy
4/29/2015	Northcoast Research	Initiated Coverage	Buy	$41.00
3/6/2015	Tigress Financial	Initiated Coverage	Buy

(Data available from 9/27/2014 forward)

Earnings History for Cynosure (NASDAQ:CYNO)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
10/25/2016
7/26/2016	Q216	$0.29	$0.36	$101.31 million	$110.30 million	View	Listen
4/26/2016	Q116	$0.14	$0.19	$85.78 million	$94.70 million	View	Listen
2/9/2016	Q415	$0.38	$0.42	$95.01 million	$102.40 million	View	Listen
10/27/2015	Q315	$0.18	$0.21	$76.68 million	$78.40 million	View	Listen
7/28/2015	Q215	$0.29	$0.30	$82.71 million	$83.70 million	View	Listen
5/5/2015	Q1	$0.09	$0.15	$70.87 million	$74.90 million	View	Listen
2/10/2015	Q414	$0.39	$0.36	$83.01 million	$86.30 million	View	Listen
10/28/2014	Q314	$0.24	$0.25	$69.94 million	$71.50 million	View	Listen
7/29/2014	Q214	$0.29	$0.32	$71.15 million	$72.60 million	View	Listen
5/6/2014	Q1	$0.23	$0.19	$64.70 million	$62.00 million	View	Listen
2/12/2014	Q413	$0.19	$0.39	$67.80 million	$74.50 million	View	Listen
10/29/2013	Q313	$0.19	$0.23	$61.60 million	$60.70 million	View	Listen
7/31/2013	Q2 2013	$0.20	$0.29	$46.96 million	$50.09 million	View	Listen
4/30/2013	Q1 2013	$0.13	$0.12	$38.51 million	$10.70 million	View	Listen
2/12/2013	Q4 2012	$0.23	$0.27	$40.98 million	$47.70 million	View	Listen
10/23/2012		$0.12	$0.25			View	N/A
7/24/2012		$0.12	$0.20			View	N/A
5/1/2012		($0.02)	$0.06			View	N/A
2/14/2012		$0.05	$0.08			View	N/A
10/25/2011		$0.04	($0.06)			View	N/A
5/3/2011		($0.05)	($0.15)			View	N/A
2/15/2011		($0.03)	($0.06)			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Cynosure (NASDAQ:CYNO)

Current Year EPS Consensus Estimate: $1.34 EPS
Next Year EPS Consensus Estimate: $1.88 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	4	$0.13	$0.26	$0.18
Q2 2016	5	$0.27	$0.37	$0.31
Q3 2016	5	$0.21	$0.35	$0.30
Q4 2016	3	$0.49	$0.71	$0.57
Q1 2017	3	$0.22	$0.33	$0.29
Q2 2017	3	$0.49	$0.54	$0.51
Q3 2017	3	$0.31	$0.44	$0.39
Q4 2017	3	$0.65	$0.84	$0.72

(Data provided by Zacks Investment Research)

Dividend History for Cynosure (NASDAQ:CYNO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Cynosure (NASDAQ:CYNO)

Insider Ownership Percentage: 2.90%
Institutional Ownership Percentage: 99.51%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
8/30/2016	Brian M Barefoot	Director	Sell	21,000	$51.66	$1,084,860.00
8/15/2016	Michael R Davin	Chairman	Sell	12,062	$53.35	$643,507.70
8/15/2016	Timothy W Baker	CFO	Sell	5,834	$53.35	$311,243.90
8/11/2016	Michael R Davin	Chairman	Sell	4,222	$53.18	$224,525.96
8/11/2016	Timothy W Baker	CFO	Sell	2,041	$53.19	$108,560.79
5/13/2016	Douglas J Delaney	VP	Sell	12,299	$46.60	$573,133.40
5/13/2016	Michael R Davin	CEO	Sell	26,271	$46.59	$1,223,965.89
5/13/2016	Timothy W Baker	CFO	Sell	12,451	$46.60	$580,216.60
4/18/2016	Douglas J Delaney	VP	Sell	15,890	$45.01	$715,208.90
4/18/2016	Michael R Davin	CEO	Sell	74,729	$45.31	$3,385,970.99
4/18/2016	Timothy W Baker	CFO	Sell	14,008	$45.02	$630,640.16
4/14/2016	Douglas J Delaney	VP	Sell	24,488	$45.02	$1,102,449.76
4/14/2016	Michael R Davin	CEO	Sell	61,377	$45.01	$2,762,578.77
4/14/2016	Timothy W Baker	CFO	Sell	39,857	$45.02	$1,794,362.14
4/13/2016	Michael R Davin	CEO	Sell	72	$45.00	$3,240.00
4/6/2016	Douglas J Delaney	VP	Sell	4,408	$45.08	$198,712.64
4/6/2016	Michael R Davin	CEO	Sell	4,869	$45.11	$219,640.59
4/6/2016	Timothy W Baker	CFO	Sell	4,413	$45.08	$198,938.04
4/4/2016	Douglas J Delaney	VP	Sell	66,626	$45.47	$3,029,484.22
4/4/2016	Michael R Davin	CEO	Sell	66,259	$45.61	$3,022,072.99
4/4/2016	Timothy W Baker	CFO	Sell	53,297	$45.60	$2,430,343.20
12/31/2015	Michael R. Davin	CEO	Sell	200	$45.00	$9,000.00
12/31/2015	Timothy W. Baker	CFO	Sell	100	$45.00	$4,500.00
6/1/2015	Ettore V Biagioni	Director	Sell	24,000	$36.25	$870,000.00
5/20/2015	Douglas J Delaney	VP	Sell	89,000	$38.01	$3,382,890.00
5/20/2015	Michael R Davin	CEO	Sell	151,000	$38.07	$5,748,570.00
4/23/2015	Michael R Davin	CEO	Sell	6,991	$33.04	$230,982.64
4/10/2015	Michael R Davin	CEO	Sell	44,677	$33.01	$1,474,787.77
4/9/2015	Douglas J Delaney	VP	Sell	28,335	$33.01	$935,338.35
4/9/2015	Michael R Davin	CEO	Sell	70,000	$32.00	$2,240,000.00
4/8/2015	Douglas J Delaney	VP	Sell	45,000	$32.00	$1,440,000.00
1/9/2015	Ettore V Biagioni	Director	Sell	12,000	$30.09	$361,080.00
12/2/2014	Ettore V Biagioni	Director	Sell	2,500	$28.00	$70,000.00
11/24/2014	Ettore V Biagioni	Director	Sell	5,000	$27.28	$136,400.00
11/5/2013	Marina Hatsopoulos	Director	Buy	3,000	$22.60	$67,800.00
9/5/2012	Douglas J Delaney	VP	Sell	16,904	$27.65	$467,395.60
9/5/2012	Michael R Davin	CEO	Sell	16,770	$27.65	$463,690.50
9/5/2012	Timothy W Baker	CFO	Sell	16,854	$27.65	$466,013.10

(Data available from 1/1/2013 forward)

Latest Headlines for Cynosure (NASDAQ:CYNO)

Date	Headline
	Global Thermal Energy Based Ablation Devices Market Trend and Forecast to 2021 (NASDAQ:CYNO) www.medgadget.com - September 27 at 4:34 PM
	Holder Move: Insight Capital Research & Management INC Lifted Its Stake in Cynosure INC (CYNO) by $3.99 Million - Chester News (NASDAQ:CYNO) www.chesterindependent.com - September 27 at 9:10 AM
	Cynosure, Inc. (NASDAQ:CYNO)'s Accounts Payable Is $29.658 - RealistInvestor.com (NASDAQ:CYNO) www.realistinvestor.com - September 26 at 9:16 AM
	Cynosure, Inc. – Value Analysis (NASDAQ:CYNO) : September 22, 2016 (NASDAQ:CYNO) www.capitalcube.com - September 22 at 4:40 PM
	Cynosure, Inc. breached its 50 day moving average in a Bullish Manner : CYNO-US : September 21, 2016 (NASDAQ:CYNO) www.capitalcube.com - September 21 at 8:50 AM
	Stock Perspective: Cynosure, Inc. (NASDAQ:CYNO) Earnings in View - Frisco Fastball (NASDAQ:CYNO) friscofastball.com - September 20 at 8:11 AM
	Shares Have Ticked Up Over the Last Five Trading Sessions: Cynosure, Inc. (NASDAQ:CYNO) - Post News (NASDAQ:CYNO) www.kentuckypostnews.com - September 20 at 8:11 AM
	Shares With Gains Over the Past Half Year: Cynosure, Inc. (NASDAQ:CYNO) - Post News (NASDAQ:CYNO) www.kentuckypostnews.com - September 19 at 3:25 PM
	What is the Sell-side Saying About Cynosure, Inc. (NASDAQ:CYNO)? - Frisco Fastball (NASDAQ:CYNO) friscofastball.com - September 18 at 4:25 PM
	Consensus Estimates on Earnings & Stock Price in Focus for Cynosure, Inc. (NASDAQ:CYNO) Shares - Frisco Fastball (NASDAQ:CYNO) friscofastball.com - September 17 at 4:26 PM
	Stock Update on Earnings & Estimates for Cynosure, Inc. (NASDAQ:CYNO) - Frisco Fastball (NASDAQ:CYNO) friscofastball.com - September 16 at 4:25 PM
	Sell-side is Weighing in on Cynosure, Inc. (NASDAQ:CYNO) Earnings - Frisco Fastball (NASDAQ:CYNO) friscofastball.com - September 16 at 4:25 PM
	Cynosure Appoints Stephen J. Webber to CFO & Other Roles (NASDAQ:CYNO) finance.yahoo.com - September 14 at 4:36 PM
	BRIEF-Cynosure to name Stephen Webber as Chief Financial Officer (NASDAQ:CYNO) www.reuters.com - September 13 at 9:25 AM
	Cynosure to Name Stephen J. Webber as New Chief Financial Officer (NASDAQ:CYNO) www.publicnow.com - September 13 at 9:25 AM
	CYNOSURE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (NASDAQ:CYNO) biz.yahoo.com - September 13 at 9:25 AM
	Shares Lower Over the Past Quarter: Cynosure, Inc. (NASDAQ ... - Post News (NASDAQ:CYNO) www.kentuckypostnews.com - September 11 at 9:03 AM
	Relative Strength Alert For Cynosure (NASDAQ:CYNO) www.nasdaq.com - September 9 at 4:24 PM
	Detailed examination of the Global dermatology devices market that projected to reach market value of $11.88 billion by 2019 (NASDAQ:CYNO) www.whatech.com - September 9 at 9:22 AM
	Placing Cynosure, Inc. (NASDAQ:CYNO) Shares Under the Microscope - Post News (NASDAQ:CYNO) www.kentuckypostnews.com - September 8 at 8:20 AM
	Cynosure, Inc. breached its 50 day moving average in a Bearish Manner : CYNO-US : September 5, 2016 (NASDAQ:CYNO) www.capitalcube.com - September 5 at 9:09 AM
	Accounts Payable For Cynosure, Inc. (NASDAQ:CYNO) Is $29.658 - RealistInvestor.com (NASDAQ:CYNO) www.realistinvestor.com - September 4 at 4:16 PM
	Cynosure, Inc. (NASDAQ:CYNO) Is Expected To Post EPS Of $0.41 - RealistInvestor.com (NASDAQ:CYNO) www.realistinvestor.com - September 4 at 4:16 PM
	Stock in Review: Taking a Closer Look at Cynosure, Inc. (NASDAQ:CYNO) Shares - Post News (NASDAQ:CYNO) www.kentuckypostnews.com - September 1 at 4:27 PM
	Shares Slipping Lower Over the Past Month: Cynosure, Inc. (NASDAQ:CYNO) - Post News (NASDAQ:CYNO) www.kentuckypostnews.com - September 1 at 4:27 PM
	Insiders Selling, Short Interest Growing Cynosure, Inc. (NASDAQ:CYNO) - Finance Daily (NASDAQ:CYNO) www.fidaily.com - September 1 at 4:27 PM
	Cynosure, Inc. (NASDAQ:CYNO) Reports Change of $1.923 MILLION IN Assets & Liabilities - RealistInvestor.com (NASDAQ:CYNO) www.realistinvestor.com - August 29 at 4:43 PM
	ETF’s with exposure to Cynosure, Inc. : August 29, 2016 (NASDAQ:CYNO) www.capitalcube.com - August 29 at 4:43 PM
	Cynosure, Inc. breached its 50 day moving average in a Bearish Manner : CYNO-US : August 26, 2016 (NASDAQ:CYNO) www.capitalcube.com - August 26 at 8:58 AM
	Will Cynosure, Inc. (NASDAQ:CYNO) Surprise This Quarter? - Investor Newswire (NASDAQ:CYNO) www.investornewswire.com - August 25 at 4:35 PM
	Analysts See Cynosure, Inc. (NASDAQ:CYNO) Reporting EPS Of $0.41 - RealistInvestor.com (NASDAQ:CYNO) www.realistinvestor.com - August 21 at 4:18 PM
	Crowd Sentiment & Wall Street Views on Cynosure, Inc. (NASDAQ:CYNO)? - Post News (NASDAQ:CYNO) www.kentuckypostnews.com - August 20 at 5:34 AM
	Consensus Take: Cynosure, Inc. (NASDAQ:CYNO) Earnings & Ratings Watch - Post News (NASDAQ:CYNO) www.kentuckypostnews.com - August 19 at 3:38 PM
	CYNOSURE INC Financials (NASDAQ:CYNO) finance.yahoo.com - August 16 at 4:38 PM
	Cynosure Announces New Innovations for Melasma Treatment and Effective Body Contouring Laser Treatment at Cynosure APAC Forum (NASDAQ:CYNO) www.chinamoneynetwork.com - August 16 at 6:58 AM
	Liposuction Surgery Devices Market Value Share, Supply Demand, share and Value Chain 2016-2026 (NASDAQ:CYNO) reports.pr-inside.com - August 13 at 4:31 PM
	Dermatology Treatment Devices Market Driving Factors, Industry Analysis, Investment Feasibility and Trends (NASDAQ:CYNO) reports.pr-inside.com - August 12 at 4:35 PM
	Cynosure, Inc. (CYNO) Ownership Up in Latest Report from Dimensional Fund Advisors Lp - Finance Daily (NASDAQ:CYNO) www.fidaily.com - August 10 at 8:15 AM
	Cynosure, Inc. (NASDAQ:CYNO) Quarterly Accounts Payable At $72.597 Millions - RealistInvestor.com (NASDAQ:CYNO) www.realistinvestor.com - August 8 at 4:40 PM
	CYNOSURE INC Files SEC form 10-Q, Quarterly Report (NASDAQ:CYNO) biz.yahoo.com - August 5 at 4:36 PM
	Dermatology Devices Market Revenue and Value Chain 2016-2026 (NASDAQ:CYNO) www.medgadget.com - August 5 at 9:46 AM
	Worldwide Facial Rejuvenation Market expected to grow at a CAGR of 4.9% from 2015-2021, According to PMR Report (NASDAQ:CYNO) www.medgadget.com - August 2 at 4:41 PM
	Looking for Healthcare Stocks? Consider These Four (NASDAQ:CYNO) www.thestreet.com - August 2 at 4:41 PM
	Cynosure, Inc. (NASDAQ:CYNO) Yearly Accounts Payable At $33.885 Millions - RealistInvestor.com (NASDAQ:CYNO) www.realistinvestor.com - August 2 at 9:20 AM
	Brokers Issue Average Price Target Of 47.59 On Cynosure, Inc. (NASDAQ:CYNO) - FTSE News (NASDAQ:CYNO) www.ftsenews.co.uk - July 29 at 9:54 PM
	Cynosure Inc. (CYNO) Hits New 52-week High During July 26 Session - Equities.com (NASDAQ:CYNO) www.equities.com - July 28 at 5:32 PM
	Cynosure Still Looks Attractive After A Bull Run - Seeking Alpha (NASDAQ:CYNO) seekingalpha.com - July 28 at 5:32 PM
	Cynosure Reports Net Income of $6.3 Million on Record Sales of $110.3 Million for the Second Quarter of 2016 (NASDAQ:CYNO) www.bizjournals.com - July 28 at 10:41 AM
	Cynosure Inc. (CYNO) Hits New 52-week High During July 26 Session (NASDAQ:CYNO) www.equities.com - July 28 at 10:41 AM
	Cynosure Inc (NASDAQ:CYNO) nearing 52-week high, short interest stable - Street Report (NASDAQ:CYNO) www.streetreport.co - July 27 at 11:00 AM